🇺🇸 FDA
Patent

US 9045752

NKX3-1 saRNA and KLF4 saRNA and uses thereof

granted A61KA61K31/7105A61P

Quick answer

US patent 9045752 (NKX3-1 saRNA and KLF4 saRNA and uses thereof) held by The Regents of the University of California expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/7105, A61P, A61P35/00